Michigan Medicine 12th Annual Western Michigan Liver Round-Up 2023

30 $

+ Include: 8 videos + 1 pdf, size: 2.71 GB

+ Target Audience: gastroenterologist, internist, family medicine physician

Description

+ Include: 8 videos + 1 pdf, size: 2.71 GB

+ Target Audience: gastroenterologist, internist, family medicine physician

+ Sample video: contact me for sample video

+ Information:

OVERVIEW

Join this hybrid program in-person and virtually. New information regarding the medical evaluation of abnormal liver function tests, medical management of NASH, and primary sclerosing cholangitis and primary biliary cholangitis will be presented. In addition, management of ascites, management of cholecystitis and laparoscopic gastric sleeve for obesity in high-risk candidates will be presented. Following the course, the participants will understand and be able to implement how to evaluate a patient with abnormal liver biochemistries; how to evaluate and treat patients with non-alcoholic fatty liver disease; how to diagnose and treat patients with chronic cholestatic liver disease; how to assess the severity of ascites, diagnose and treat SBP, and understand the indications and outcomes with IV albumin use in patients with cirrhosis; radiological, endoscopic, and surgical approaches to cholecystitis; and indications and limitations of laparoscopic sleeve gastrectomy.

TARGET AUDEINCE

This activity is appropriate for:
House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers

In the fields of:
Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Transplant Surgery

LEARNING OBJECTIVES

At the end of this activity, participant should be able to:

  1. Understand the recommended indications and outcomes with radiological and endoscopic approaches to cholecystitis
  2. Diagnose and treat patients with fatty liver disease
  3. Understand the recommended indications and outcomes with IV albumin use in patients with advanced cirrhosis
  4. Evaluate patients with abnormal LFT’s using serological, radiological and histological approaches
  5. Understand the latest recommendations for the diagnosis and treatment of patients with PSC and PBC
  6. Refer appropriate patients with obesity and metabolic syndrome for laparoscopic sleeve gastrectomy

 

+ Topics:

12thannualWesternliverroundup071323_0714_075510.pdf
Laparoscopic Gastric Sleeve for Obesity in High Risk Candidates Including ESRD Patients.mp4
Management of Ascites, Spontaneous Bacterial Peritonitis, and Use of Albumin.mp4
Management of Cholecystitis in Patients with Liver Disease.mp4
Medical Evaluation of Abnormal Liver Function Tests and Interpreting Iron Studies.mp4
Medical Management of NASH.mp4
Panel Question & Answers 1.mp4
Panel Question and Answers 2.mp4
What’s New in Primary Sclerosing Cholangitis and Primary Biliary Cholangitis.mp4

Reviews

There are no reviews yet.

Be the first to review “Michigan Medicine 12th Annual Western Michigan Liver Round-Up 2023”

Your email address will not be published. Required fields are marked *